Improvement in monitoring prostate cancer

One out of six men has a lifetime risk of develop prostate cancer, with one out of ten proving to be fatal. More men have been treated for prostate cancer based on prostate specific antigen (PSA), a blood test that detects probable prostate cancer which leads to a biopsy of the male gland. Treatment can include radiotherapy, chemotherapy and surgery, which all have complications that can lead to a decreased quality of life, including impotence and incontinence, with no necessary increase in quantity of life. Watchful waiting is another poorly accepted viable treatment where the cancer is closely monitored for changes over time. A nomogram is being proposed for specialist use to model patients who are more likely to be suffering from aggressive prostate cancer, thereby indicating which cases are more suitable for treatment. Anxiety, stress, pain, discomfort, infection and bleeding can be reduced by limiting biopsies to those who are at higher risk of malignant cancer by taking into account a person's age, digital rectal examination, and PSA density (PSA compared to prostate volume).

Source: summary of medical news story as reported by EMax Health

Related Disease Topics:

• Prostate cancer
• Cancer
• Aggressive prostate cancer
• Malignant cancer

Related Symptom Topics:

• Impotence
• Incontinence
• Anxiety
• Stress
• Pain
• Discomfort
• Infection
• Bleeding

Article Source Details

About: Improvement in monitoring prostate cancer

Date: 12 July 2005

Source: EMax Health

URL: http://www.emaxhealth.com/33/2555.html

Related Medical Topics

This summary article refers to the following medical categories:

• Surgery
• Surgery and impotence
• Surgery and incontinence
• Surgery and anxiety
• Surgery and stress
• Surgery and pain
• Surgery and discomfort
• Surgery and infection
• Surgery and bleeding
• Surgery and prostate cancer
• Surgery and cancer
• Surgery and aggressive prostate cancer
• Surgery and malignant cancer
• Surgery and biopsy
• Death from prostate cancer
• Death from aggressive cancer
• Death from aggressive prostate cancer
• Risk and prostate cancer
• Risk and aggressive cancer
• Risk and biopsy
• Risk and malignant cancer
• Risk and infection
• Risk and pain
• Risk and discomfort
• Diagnosis and prostate cancer
• Diagnosis and cancer
• Diagnosis and aggressive prostate cancer
• Diagnosis and malignant cancer
• Diagnosis and digital rectal examination
• Diagnosis and prostate specific antigen
• Diagnosis and PSA
• Research and ultrasound
• Research
• Research and prostate cancer
• Research and cancer
• Research and aggressive prostate cancer
• Research and malignant cancer
• Research and digital rectal examination
• Research and prostate specific antigen
• Research and PSA
• Research and ultrasound
• Research and prostate cancer risk
• Side effects
• Side effects and impotence
• Side effects and incontinence
• Side effects and pain
• Side effects and pain
• Side effects and infection
• Side effects and bleeding
• Side effects and prostate cancer treatment
• Side effects and radiotherapy
• Side effects and prostate surgery
• Side effects and chemotherapy

More News Topics

Search Specialists by State and City